Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 27-02-2015 | Practice Area: | Equity Capital Markets |
| Deal Title: | Ascendis Pharma NASDAQ Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Simmons and Simmons advised Ascendis Pharma AS on the German law aspects of its USD108 million Initial Public Offering on NASDAQ.
Ascendis Pharma is a biopharmaceutical company focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs.
The Simmons and Simmons team was led by Dusseldorf based corporate and M and A partner Stephan Ulrich.
|
||
| Financial Center: | Dusseldorf | Value: | 100.01-500.00 |
| Advised Party: | Issuer | Law Firm | Simmons & Simmons |
| Issuer Jurisdiction- | Germany | Listing Jurisdiction- | Germany |
| Classification: |
Initial Public Offerings NASDAQ |
Lawyer | Stephan Ulrich |
